OBJECTIVE: Epilepsy neurosurgery is a treatment option for children with refractory epilepsy. Our aim was to determine if outcomes improved over time. METHODS: Pediatric epilepsy surgery patients operated in the first 11 years (1986-1997; pre-1997) were compared with the second 11 years (1998-2008; post-1997) for differences in presurgical and postsurgical variables. RESULTS: Despite similarities in seizure frequency, age at seizure onset, and age at surgery, the post-1997 series had more lobar/focal and fewer multilobar resections, and more patients with tuberous sclerosis complex and fewer cases of nonspecific gliosis compared with the pre-1997 group. Fewer cases had intracranial EEG studies in the post-1997 (0.8%) compared with the pre-1997 group (9%). Compared with the pre-1997 group, the post-1997 series had more seizure-free patients at 0.5 (83%, +16%), 1 (81%, +18%), 2 (77%, +19%), and 5 (74%, +29%) years, and more seizure-free patients were on medications at 0.5 (97%, +6%), 1 (88%, +9%), and 2 (76%, +29%), but not 5 (64%, +8%) years after surgery. There were fewer complications and reoperations in the post-1997 series compared with the pre-1997 group. Logistic regression identified post-1997 series and less aggressive medication withdrawal as the main predictors of becoming seizure-free 2 years after surgery. CONCLUSIONS: Improved technology and surgical procedures along with changes in clinical practice were likely factors linked with enhanced and sustained seizure-free outcomes in the post-1997 series. These findings support the general concept that clearer identification of lesions and complete resection are linked with better outcomes in pediatric epilepsy surgery patients.
OBJECTIVE:Epilepsy neurosurgery is a treatment option for children with refractory epilepsy. Our aim was to determine if outcomes improved over time. METHODS: Pediatric epilepsy surgery patients operated in the first 11 years (1986-1997; pre-1997) were compared with the second 11 years (1998-2008; post-1997) for differences in presurgical and postsurgical variables. RESULTS: Despite similarities in seizure frequency, age at seizure onset, and age at surgery, the post-1997 series had more lobar/focal and fewer multilobar resections, and more patients with tuberous sclerosis complex and fewer cases of nonspecific gliosis compared with the pre-1997 group. Fewer cases had intracranial EEG studies in the post-1997 (0.8%) compared with the pre-1997 group (9%). Compared with the pre-1997 group, the post-1997 series had more seizure-free patients at 0.5 (83%, +16%), 1 (81%, +18%), 2 (77%, +19%), and 5 (74%, +29%) years, and more seizure-free patients were on medications at 0.5 (97%, +6%), 1 (88%, +9%), and 2 (76%, +29%), but not 5 (64%, +8%) years after surgery. There were fewer complications and reoperations in the post-1997 series compared with the pre-1997 group. Logistic regression identified post-1997 series and less aggressive medication withdrawal as the main predictors of becoming seizure-free 2 years after surgery. CONCLUSIONS: Improved technology and surgical procedures along with changes in clinical practice were likely factors linked with enhanced and sustained seizure-free outcomes in the post-1997 series. These findings support the general concept that clearer identification of lesions and complete resection are linked with better outcomes in pediatric epilepsy surgery patients.
Authors: Patrick Kwan; Alexis Arzimanoglou; Anne T Berg; Martin J Brodie; W Allen Hauser; Gary Mathern; Solomon L Moshé; Emilio Perucca; Samuel Wiebe; Jacqueline French Journal: Epilepsia Date: 2009-11-03 Impact factor: 5.864
Authors: P D Adelson; W J Peacock; H T Chugani; Y G Comair; H V Vinters; W D Shields; D A Shewmon Journal: Pediatr Neurosurg Date: 1992 Impact factor: 1.162
Authors: Shon W Cook; Snow T Nguyen; Bin Hu; Sue Yudovin; W Donald Shields; Harry V Vinters; Barbara M Van de Wiele; Rick E Harrison; Gary W Mathern Journal: J Neurosurg Date: 2004-02 Impact factor: 5.115
Authors: R Jonas; S Nguyen; B Hu; R F Asarnow; C LoPresti; S Curtiss; S de Bode; S Yudovin; W D Shields; H V Vinters; G W Mathern Journal: Neurology Date: 2004-05-25 Impact factor: 9.910
Authors: D Barry Sinclair; Keith E Aronyk; Thomas J Snyder; B Matt Wheatley; John D S McKean; Ravi Bhargava; M Hoskinson; Chunhai Hao; William F Colmers; Marjorie Berg; William Mak Journal: Pediatr Neurol Date: 2003-10 Impact factor: 3.372
Authors: Jeong Ho Lee; My Huynh; Jennifer L Silhavy; Sangwoo Kim; Tracy Dixon-Salazar; Andrew Heiberg; Eric Scott; Vineet Bafna; Kiley J Hill; Adrienne Collazo; Vincent Funari; Carsten Russ; Stacey B Gabriel; Gary W Mathern; Joseph G Gleeson Journal: Nat Genet Date: 2012-06-24 Impact factor: 38.330
Authors: Siobhan West; Sarah J Nevitt; Jennifer Cotton; Sacha Gandhi; Jennifer Weston; Ajay Sudan; Roberto Ramirez; Richard Newton Journal: Cochrane Database Syst Rev Date: 2019-06-25
Authors: Carlos Cepeda; Jane Y Chen; Joyce Y Wu; Robin S Fisher; Harry V Vinters; Gary W Mathern; Michael S Levine Journal: Neurobiol Dis Date: 2013-10-10 Impact factor: 5.996
Authors: Carlos Cepeda; Véronique M André; Jason S Hauptman; Irene Yamazaki; My N Huynh; Julia W Chang; Jane Y Chen; Robin S Fisher; Harry V Vinters; Michael S Levine; Gary W Mathern Journal: Neurobiol Dis Date: 2011-08-23 Impact factor: 5.996
Authors: Christine B Baca; Huibrie C Pieters; Tomoko J Iwaki; Gary W Mathern; Barbara G Vickrey Journal: Epilepsia Date: 2015-04-20 Impact factor: 5.864
Authors: Carlos Cepeda; Julia W Chang; Geoffrey C Owens; My N Huynh; Jane Y Chen; Conny Tran; Harry V Vinters; Michael S Levine; Gary W Mathern Journal: CNS Neurosci Ther Date: 2014-12-01 Impact factor: 5.243
Authors: Bledi Brahimaj; Hansel M Greiner; James L Leach; Paul S Horn; Charles B Stevenson; Lili Miles; Anna Byars; Katherine Holland; Mary Sutton; Francesco T Mangano Journal: Childs Nerv Syst Date: 2014-04-26 Impact factor: 1.475
Authors: Hisako Fujiwara; Hansel M Greiner; Ki Hyeong Lee; Katherine D Holland-Bouley; Joo Hee Seo; Todd Arthur; Francesco T Mangano; James L Leach; Douglas F Rose Journal: Epilepsia Date: 2012-08-20 Impact factor: 5.864